Essentials of Stem Cell Biology
- 4th Edition - November 1, 2025
- Imprint: Academic Press
- Editors: Robert Lanza, Anthony Atala
- Language: English
- Hardback ISBN:9 7 8 - 0 - 4 4 3 - 1 5 4 2 0 - 1
- eBook ISBN:9 7 8 - 0 - 4 4 3 - 1 6 0 4 3 - 1
First developed as an accessible abridgement of the successful Handbook of Stem Cells, Essentials of Stem Cell Biology serves the needs of the evolving population of scientist… Read more
Purchase options
Institutional subscription on ScienceDirect
Request a sales quoteFirst developed as an accessible abridgement of the successful Handbook of Stem Cells, Essentials of Stem Cell Biology serves the needs of the evolving population of scientists, researchers, practitioners, and students embracing the latest advances in stem cells. Representing the combined effort of 7 editors and more than 200 scholars and scientists whose pioneering work has defined our understanding of stem cells, this book combines the prerequisites for a general understanding of adult and embryonic stem cells with a presentation by the world's experts of the latest research information about specific organ systems. From basic biology/mechanisms, early development, ectoderm, mesoderm, endoderm, and methods to the application of stem cells to specific human diseases, regulation and ethics, and patient perspectives, no topic in the field of stem cells is left uncovered.
- Contributions by Nobel Laureates and leading international investigators
- Includes two entirely new chapters devoted exclusively to induced pluripotent stem (iPS) cells written by the scientists who made the breakthrough
- Edited by a world-renowned author and researcher to present a complete story of stem cells in research, in application, and as the subject of political debate
- Presented in full color with a glossary, highlighted terms, and bibliographic entries replacing references
researchers, grad students, and professionals working with human stem cells in biology, tissue engineering, genetics, cancer research, virology, immunology, and biotechnology
PART ONE: INTRODUCTION TO STEM CELLS
1. Why Stem Cell Research? Advances in the Field
1.1 The Origins of Stem Cell Technology
1.2 Organizations that Advocate and Support the Growth of the Stem Cell Sector
1.3 Applications of Stem Cells in Medicine
1.4 Challenges to the Use of Stem Cells
2. ‘Stemness’: Definitions, Criteria, and Standards
2.1 What is a Stem Cell?
2.2 Self-Renewal
2.3 Potency
2.4 Clonality
2.5 Definition
2.6 Where do Stem Cells Come from?
2.7 Stem Cells of the Early Embryo
2.8 Ontogeny of Adult Stem Cells
2.9 How are Stem Cells Identified, Isolated, and Characterized?
2.10 Embryonic Stem Cells
2.11 Adult Stem Cells
2.12 Stemness: Progress Toward a Molecular Definition of Stem Cells
3. Pluripotent Stem Cells from Vertebrate Embryos: Present Perspective and Future Challenges
3.1 Introduction
3.2 Biology of ES and ESL Cells
3.3 Stem Cell Therapy
3.4 Summary
4. Embryonic Stem Cells in Perspective
4.1 Embryonic Stem Cells in Perspective
5. The Development of Epithelial Stem Cell Concepts
5.1 Introduction
5.2 A Definition of Stem Cells
5.3 Hierarchically Organized Stem Cell Populations
5.4 Skin Stem Cells
5.5 The Intestinal Stem Cell System
5.6 Stem Cell Organization on the Tongue
5.7 Generalized Scheme
5.8 Summary
PART TWO: BASIC BIOLOGY/MECHANISMS
6. Stem Cell Niches
6.1 Stem Cell Niche Hypothesis
6.2 Stem Cell Niches in the Drosophila Germ-Line
6.3 The Germ-Line Stem Cell Niche in the Drosophila Ovary
6.4 Germ-Line Stem Cell Niche in the Drosophila Testis
6.5 Coordinate Control of Germ-Line Stem Cell and Somatic Stem Cell Maintenance and Proliferation
6.6 Structural Components of the Niche
6.7 Stem Cell Niches Within Mammalian Tissues
6.8 Summary
7. Mechanisms of Stem Cell Self-Renewal
7.1 Self-Renewal of Pluripotent Stem Cells
7.2 Prevention of Differentiation
7.3 Maintenance of Stem Cell Proliferation
7.4 Maintenance of Telomere Length
7.5 X Chromosome Inactivation
7.6 Summary
8. Cell Cycle Regulators in Stem Cells
8.1 Introduction
8.2 Cell Cycle Kinetics of Stem Cells In Vivo
8.3 Stem Cell Expansion Ex Vivo
8.4 Mammalian Cell Cycle Regulation and Cyclin-Dependent Kinase Inhibitors
8.5 Roles of Cyclin-Dependent Kinase Inhibitors in Stem Cell Regulation
8.6 Roles of p21 in Stem Cell Regulation
8.7 Roles of p27 in Stem Cell Regulation
8.8 Other Cyclin-Dependent Kinase Inhibitors and the Retinoblastoma Pathway in Stem Cell Regulation
8.9 Relation Between Cyclin-Dependent Kinase Inhibitors and Transforming Growth Factor β-1
8.10 CKIs and Notch
8.11 Summary and Future Directions
9. How Cells Change Their Phenotype
9.1 Metaplasia and Transdifferentiation
9.2 Examples of Transdifferentiation
9.3 Barrett’s Metaplasia
9.4 Regeneration
9.5 Bone Marrow to Other Cell Types
9.6 Dedifferentiation as a Prerequisite for Transdifferentiation
9.7 How to Change a Cell’s Phenotype Experimentally
9.8 Summary
PART THREE: TISSUE AND ORGAN DEVELOPMENT
10. Differentiation in Early Development
10.1 Preimplantation Development
10.2 Cell Polarization Occurs During Compaction
10.3 Axis Specification During Preimplantation in the Mouse
10.4 Developmental Potency of the Early Mouse Embryo
10.5 Genes Important During Preimplantation Mouse Development
10.6 From Implantation to Gastrulation
10.7 The Mouse Trophectoderm and Primitive Endoderm Cells
10.8 Development of the Mouse Inner Cell Mass to the Epiblast
10.9 The Human Embryo
10.10 Implantation: Maternal Versus Embryonic Factors
10.11 The Role of Extra-Embryonic Tissues in Patterning the Mouse Embryo
11. Stem Cells Derived from Amniotic Fluid
11.1 Amniotic Fluid – Function, Origin, and Composition
11.2 Amniotic Fluid Mesenchymal Stem Cells
11.3 Amniotic Fluid Stem Cells
11.4 Conclusions
12. Stem and Progenitor Cells Isolated from Cord Blood
12.1 Addressing Delayed Time to Engraftment and Graft Failure With CB
12.2 Cryopreservation of CB Cells
12.3 Induced Pluripotent Stem Cells Generated from CB
12.4 Concluding Comments
13. The Nervous System
13.1 Introduction
13.2 Neural Development
13.3 Neural Stem Cells
13.4 Neural Differentiation of Mouse ES Cells
13.5 Neural Differentiation of Human and Nonhuman Primate ES Cells
13.6 Developmental Perspectives
13.7 Therapeutic Perspectives
13.8 Parkinson’s Disease
13.9 Huntington’s Disease
13.10 Stroke
13.11 Demyelination
13.12 Summary
14. Sensory Epithelium of the Eye and Ear
14.1 Introduction
14.2 Introduction to Progenitor and Stem Cells in the Retina
14.3 The Optic Vesicle Generates Diverse Cell Types that can Undergo Transdifferentiation
14.4 In Vivo Neurogenesis in the Posthatch Chicken
14.5 Growth of Retinal Neurospheres from the Ciliary Margin of Mammal
14.6 Prospects for Stem Cell Therapy in the Retina
14.7 Development and Regeneration of Tissues Derived from the Inner Ear
14.8 In Vivo Neurogenesis in Postembryonic Animals
14.9 In Vitro Expansion of Otic Progenitors
14.10 Prospects for Therapy
15. Epithelial Skin Stem Cells
15.1 A Brief Introduction to Mouse Skin Organization
15.2 The Bulge as a Residence of Epithelial Skin Stem Cells
15.3 Models of Epithelial Stem Cell Activation
15.4 Molecular Fingerprint of the Bulge – Putative Stem Cell Markers
15.5 Cell Signaling in Multipotent Epithelial Skin Stem Cells
15.6 Commentary and Future Directions
16. Hematopoietic Stem Cells
16.1 Embryonic Stem Cells and Embryonic Hematopoiesis
16.2 Blood Formation in Embryoid Bodies
16.3 Transformation of an EB-Derived HSC by BCR/ABL
16.4 Promoting Hematopoietic Engraftment with STAT5 and HOXB4
16.5 Promoting Blood Formation In Vitro with Embryonic Morphogens
17. Peripheral Blood Stem Cells
17.1 Introduction
17.2 Types and Source of Stem Cells in the Peripheral Blood
17.3 Endothelial Progenitor Cells
17.4 Mesenchymal Stem Cells
17.5 Therapeutic Applications of Peripheral Blood Stem Cells
17.6 Conclusions and Future Directions
18. Multipotent Adult Progenitor Cells
18.1 Pluripotent Stem Cells – Embryonic Stem Cells
18.2 Postnatal Tissue-Specific Stem Cells – Are Some More than Multipotent?
18.3 Can Pluripotency Be Acquired?
18.4 Isolation of Rodent MAPCs
18.5 Isolation of Human MAPCs
18.6 Recent Developments
19. Mesenchymal Stem Cells
19.1 The Definition of MSCs
19.2 The Stem Cell Nature of MSCs
19.3 Which Tissues Contain MSCS?
19.4 MSC Isolation Techniques
19.5 Immunomodulatory Effects of MSCS
19.6 Skeletal Tissue Regeneration by MSCS
19.7 Non-Skeletal Tissue Regeneration by MSCS
19.8 Conclusions
20. Skeletal Muscle Stem Cells
20.1 Introduction
20.2 The Original Muscle Stem Cell: The Satellite Cell
20.3 Functional and Biochemical Heterogeneity Among Muscle Stem Cells
20.4 Unorthodox Origins of Skeletal Muscle
20.5 The Muscle Stem Cell Niche
20.6 Conclusion
21. Stem Cells and the Regenerating Heart
21.1 Introduction
21.2 Recruiting Circulating Stem Cell Reserves
21.3 The Elusive Cardiac Stem Cell
21.4 Evolving Concepts of Regeneration
22. Cell Lineages and Stem Cells in the Embryonic Kidney
22.1 The Anatomy of Kidney Development
22.2 Genes that Control Early Kidney Development
22.3 The Establishment of Additional Cell Lineages
22.4 What Constitutes a Renal Stem Cell?
23. Adult Liver Stem Cells
23.1 Organization and Functions of Adult Mammalian Liver
23.2 Liver Stem Cells
24. Pancreatic Stem Cells
24.1 Introduction
24.2 Definition of Stem Cells and of Progenitor Cells
24.3 Progenitor Cells During Embryonic Development of the Pancreas
24.4 Progenitor Cells in the Adult Pancreas
24.5 Forcing Other Tissues to Adopt a Pancreatic Phenotype
24.6 In Vitro Studies
24.7 Summary
25. Stem Cells in the Gastrointestinal Tract
25.1 Introduction
25.2 Gastrointestinal Mucosa Contains Multiple Lineages
25.3 Epithelial Cell Lineages Originate from a Common Precursor Cell
25.4 Single Intestinal Stem Cells Regenerate Whole Crypts Containing all Epithelial Lineages
25.5 Mouse Aggregation Chimeras Show that Intestinal Crypts are Clonal Populations
25.6 Somatic Mutations in Stem Cells Reveal Stem Cell Hierarchy and Clonal Succession
25.7 Human Intestinal Crypts Contain Multiple Epithelial Cell Lineages Derived from a Single Stem Cell
25.8 Bone Marrow Stem Cells Contribute to Gut Repopulation After Damage
25.9 Gastrointestinal Stem Cells Occupy a Niche Maintained by ISEMFs in the Lamina Propria
25.10 Multiple Molecules Regulate Gastrointestinal Development, Proliferation, and Differentiation
25.11 Wnt/β-Catenin Signaling Pathway Controls Intestinal Stem Cell Function
25.12 Transcription Factors Define Regional Gut Specification and Intestinal Stem Cell Fate
25.13 Gastrointestinal Neoplasms Originate in Stem Cell Populations
25.14 Summary
PART FOUR: METHODS
26. Induced Pluripotent Stem Cells
26.1 Generation of iPS Cells
26.2 Molecular Mechanisms in iPS Cell Induction
26.3 Recapitulation of Disease Ontology and Drug Screening
26.4 iPS Cell Banking
26.5 Safety Concerns for Medical Application
26.6 Medical Application
26.7 Direct Fate Switch
26.8 Conclusion
27. Embryonic Stem Cells: Derivation and Properties
27.1 Derivation of Embryonic Stem Cells
27.2 Culture of Embryonic Stem Cells
27.3 Developmental Potential of Embryonic Stem Cells
27.4 Conclusion
28. Isolation and Maintenance of Murine Embryonic Stem Cells
28.1 Introduction
28.2 Maintenance of Embryonic Stem Cells
28.3 Media
28.4 Sera
28.5 Colony-Forming Assay for Testing Culture Conditions
28.6 Embryonic Stem Cell Passage Culture
28.7 Isolation of New Embryonic STEM Cell Lines
28.8 Method for Deriving Embryonic Stem Cells
28.9 Summary
29. Approaches for Derivation and Maintenance of Human Embryonic Stem Cells: Detailed Procedures and Alternatives
29.1 Introduction
29.2 Setting Up the Lab
29.3 Preparing and Screening Reagents
29.4 Mechanical Passaging of hES Cell Colonies
29.5 Derivation of hES Cells
29.6 Maintenance of Established hES Cell Cultures
29.7 Freezing hES Cells
29.8 Thawing hES Cells
29.9 hES Cell Quality Control
30. Derivation and Differentiation of Human Embryonic Germ Cells
30.1 Introduction
30.2 Human Embryonic Germ Cell Derivation
30.3 Embryoid Body-Derived Cells
31. Genomic Reprogramming
31.1 Introduction
31.2 Genomic Reprogramming in Germ Cells
31.3 Reprogramming Somatic Nuclei
31.4 Conclusions
PART FIVE: APPLICATIONS
32. Neural Stem Cells – Therapeutic Applications in Neurodegenerative Diseases
32.1 Introduction
32.2 Definition of Neural Stem Cells
32.3 Therapeutic Potential of Neural Stem Cells
32.4 Gene Therapy Using Neural Stem Cells
32.5 Cell Replacement Using Neural Stem Cells
32.6 ‘Global’ Cell Replacement Using Neural Stem Cells
32.7 Neural Stem Cells Display an Inherent Mechanism for Rescuing Dysfunctional Neurons
32.8 Neural Stem Cells as the Glue That Holds Multiple Therapies Together
32.9 Summary
33. Adult Progenitor Cells as a Potential Treatment for Diabetes
33.1 Importance of β-Cell Replacement Therapy for Diabetes and the Shortage of Insulin-Producing Cells
33.2 Potential of Adult Stem-Progenitor Cells as a Source of Insulin-Producing Cells
33.3 Defining β-Cells, Stem Cells, and Progenitor Cells
33.4 New β-Cells are Formed Throughout Adult Life
33.5 What is the Cellular Origin of Adult Islet Neogenesis?
33.6 Transdifferentiation of Nonislet Cells to Islet Cells
33.7 Pancreatic Acinar Cell Transdifferentiation
33.8 Bone Marrow Cells as a Source of Insulin-Producing Cells
33.9 Liver as a Source of Insulin-Producing Cells
33.10 Engineering Other Non-β-Cells to Produce Insulin
33.11 Attempts to Deliver Insulin Through Constitutive Rather Than Regulated Secretion
33.12 Summary
34. Burns and Skin Ulcers
34.1 Introduction
34.2 Burns and Skin Ulcers – The Problem
34.3 Epidermal Stem Cells
34.4 Stem Cells in Burns and Skin Ulcers – Current Use
34.5 Recent and Future Developments
35. Stem Cells and Heart Disease
35.1 Heart: A Self-renewing Organ
35.2 Distribution of CSCS in the Heart
35.3 Repair of Myocardial Damage by Nonresident Primitive Cells
35.4 Repair of Myocardial Damage by Resident Primitive Cells
35.5 Myocardial Regeneration in Humans
36. Stem Cells for the Treatment of Muscular Dystrophy
36.1 Introduction
36.2 Myoblast Transplantation – Past Failure and New Hope
36.3 Unconventional Myogenic Progenitors
36.4 Pluripotent Stem Cells for Future Cell-Based Therapies
36.5 Future Perspectives
37. Cell Therapy for Liver Disease: From Hepatocytes to Stem Cells
37.1 Introduction
37.2 Background Studies
37.3 Integration of Hepatocytes Following Transplantation
37.4 Clinical Hepatocyte Transplantation
37.5 Hepatocyte Bridge
37.6 Hepatocyte Transplantation in Acute Liver Failure
37.7 Hepatocyte Transplantation for Metabolic Liver Disease
37.8 Hepatocyte Transplantation – Novel Uses, Challenges, and Future Directions
37.9 Conclusion
38. Orthopedic Applications of Stem Cells
38.1 Introduction
38.2 Bone
38.3 Cartilage
38.4 Meniscus
38.5 Ligaments and Tendons
38.6 Spine
38.7 Summary
39. Embryonic Stem Cells in Tissue Engineering
39.1 Introduction
39.2 Tissue Engineering Principles and Perspectives
39.3 Limitations and Hurdles of Using ES Cells in Tissue Engineering
39.4 Summary
PART SIX: REGULATION AND ETHICS
40. Ethical Considerations
40.1 Introduction
40.2 Is it Morally Permissible to Destroy a Human Embryo?
40.3 Should we Postpone hES Cell Research?
40.4 Can We Benefit from Others’ Destruction of Embryos?
40.5 Can We Create an Embryo to Destroy it?
40.6 Should We Clone Human Embryos?
40.7 What Ethical Guidelines Should Govern hES Cell and Therapeutic Cloning Research?
40.8 Summary
41. Overview of the FDA Regulatory Process
41.1 Introduction and Chapter Overview
41.2 Brief Legislative History of FDA
41.3 Laws, Regulations, and Guidance
41.4 FDA Organization and Jurisdictional Issues
41.5 Approval Mechanisms and Clinical Studies
41.6 Meetings with Industry, Professional Groups, and Sponsors
41.7 Regulations and Guidance of Special Interest for Regenerative Medicine
41.8 FDA’s Standards Development Program
41.9 Advisory Committee Meetings
41.10 FDA Research and Critical Path Science
41.11 Other Communication Efforts
41.12 Conclusion
42. It’s Not about Curiosity, It’s about Cures: Stem Cell Research – People Help Drive Progress
42.1 Choosing Life
42.2 Size of the Promise
42.3 Personal Promises Fuel Progress
42.4 Hope Versus Hype
42.5 Giving Life
42.6 People Drive Progress
42.7 Better Health for All
- Edition: 4
- Published: November 1, 2025
- Imprint: Academic Press
- No. of pages: 600
- Language: English
- Hardback ISBN: 9780443154201
- eBook ISBN: 9780443160431
RL
Robert Lanza
Robert Lanza is an American scientist and author whose research spans the range of natural science, from biology to theoretical physics. TIME magazine recognized him as one of the “100 Most Influential People in the World,” and Prospect magazine named him one of the Top 50 “World Thinkers.” He has hundreds of scientific publications and over 30 books, including definitive references in the fields of stem cells, tissue engineering, and regenerative medicine. He’s a former Fulbright Scholar and studied with polio-pioneer Jonas Salk and Nobel laureates Gerald Edelman (known for his work on the biological basis of consciousness) and Rodney Porter. He also worked closely (and co-authored papers in Science on self-awareness and symbolic communication) with noted Harvard psychologist BF Skinner. Dr. Lanza was part of the team that cloned the world’s first human embryo, the first endangered species, and published the first-ever reports of pluripotent stem cell use in humans.
Affiliations and expertise
Astellas Institute for Regenerative Medicine, Westborough, MA, USAAA
Anthony Atala
Anthony Atala, MD, is the G. Link Professor and Director of the Wake Forest Institute for Regenerative Medicine, and the W. Boyce Professor and Chair of Urology. Dr. Atala is a practicing surgeon and a researcher in the area of regenerative medicine. Fifteen applications of technologies developed in Dr. Atala's laboratory have been used clinically. He is Editor of 25 books and 3 journals. Dr. Atala has published over 800 journal articles and has received over 250 national and international patents. Dr. Atala was elected to the Institute of Medicine of the National Academies of Sciences, to the National Academy of Inventors as a Charter Fellow, and to the American Institute for Medical and Biological Engineering.
Dr. Atala has led or served several national professional and government committees, including the National Institutes of Health working group on Cells and Developmental Biology, the National Institutes of Health Bioengineering Consortium, and the National Cancer Institute’s Advisory Board. He is a founding member of the Tissue Engineering Society, Regenerative Medicine Foundation, Regenerative Medicine Manufacturing Innovation Consortium, Regenerative Medicine Development Organization, and Regenerative Medicine Manufacturing Society.
Affiliations and expertise
G. Link Professor and Director of the Wake Forest Institute for Regenerative Medicine; W. Boyce Professor and Chair, Department of Urology, and G. Link Professor and Director, Wake Forest Institute for Regenerative Medicine, Wake Forest University. Winston Salem, North Carolina, USA